+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Pulmatrix Inc - logo
Autoimmune Collaboration and Licensing Deals 2016-2024 - Product Thumbnail Image

Autoimmune Collaboration and Licensing Deals 2016-2024

  • Report
  • April 2024
  • 500 Pages +
  • Global
From
Aspergillosis Treatment Market Size, Share & Trends Analysis Report By Type (Allergic, Chronic, Invasive), By Drug Class (Antifungal), By Route Of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2023 - 2030 - Product Thumbnail Image

Aspergillosis Treatment Market Size, Share & Trends Analysis Report By Type (Allergic, Chronic, Invasive), By Drug Class (Antifungal), By Route Of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2023 - 2030

  • Report
  • September 2023
  • 100 Pages
  • Global
From
US Non-postoperative Acute Pain - Market Insights, Epidemiology, and Market Forecast - 2032 - Product Thumbnail Image

US Non-postoperative Acute Pain - Market Insights, Epidemiology, and Market Forecast - 2032

  • Report
  • January 2024
  • 129 Pages
  • United States
From
United States Aspergillosis Treatment Market, By Region, By Competition Forecast & Opportunities, 2018-2028F - Product Thumbnail Image

United States Aspergillosis Treatment Market, By Region, By Competition Forecast & Opportunities, 2018-2028F

  • Report
  • November 2023
  • 75 Pages
  • United States
From
Migraine - Pipeline Insight, 2024 - Product Thumbnail Image

Migraine - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Serotonin 1B receptor agonists - Pipeline Insight, 2024 - Product Thumbnail Image

Serotonin 1B receptor agonists - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Hedgehog Pathway Inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

Hedgehog Pathway Inhibitors - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Beta Receptor Agonist - Pipeline Insight, 2024 - Product Thumbnail Image

Beta Receptor Agonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 120 Pages
  • Global
From
Aspergillosis - Pipeline Insight, 2024 - Product Thumbnail Image

Aspergillosis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 50 Pages
  • Global
From
Tyrosine Protein Kinase CSK (C Src Kinase or Protein Tyrosine Kinase CYL or CSK or EC 2.7.10.2) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Tyrosine Protein Kinase CSK (C Src Kinase or Protein Tyrosine Kinase CYL or CSK or EC 2.7.10.2) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • November 2022
  • 53 Pages
  • Global
From
Beta-2 Receptors Agonist - Pipeline Insight, 2024 - Product Thumbnail Image

Beta-2 Receptors Agonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Migraine - Pipeline Review, H2 2020 - Product Thumbnail Image

Migraine - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 342 Pages
  • Global
From
Tyrosine Protein Kinase SYK - Pipeline Review, H2 2020 - Product Thumbnail Image

Tyrosine Protein Kinase SYK - Pipeline Review, H2 2020

  • Drug Pipelines
  • July 2020
  • 121 Pages
  • Global
From
Tyrosine Protein Kinase CSK - Pipeline Review, H1 2020 - Product Thumbnail Image

Tyrosine Protein Kinase CSK - Pipeline Review, H1 2020

  • Drug Pipelines
  • June 2020
  • 96 Pages
  • Global
From
Tyrosine Protein Kinase SYK (Spleen Tyrosine Kinase or p72 Syk or SYK or EC 2.7.10.2) - Drugs in Development, 2021 - Product Thumbnail Image

Tyrosine Protein Kinase SYK (Spleen Tyrosine Kinase or p72 Syk or SYK or EC 2.7.10.2) - Drugs in Development, 2021

  • Drug Pipelines
  • March 2021
  • Global
From
Pulmatrix (PULM:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry - Product Thumbnail Image

Pulmatrix (PULM:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry

  • Company Profile
  • January 2024
  • 89 Pages
From
Comprehensive Report on Pulmatrix Inc, including SWOT, PESTLE and Business Model Canvas - Product Thumbnail Image

Comprehensive Report on Pulmatrix Inc, including SWOT, PESTLE and Business Model Canvas

  • SWOT Analysis
  • August 2023
  • 90 Pages
From
Loading Indicator